The table below shows Organon & Co.'s income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
Line item
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Revenue
$6.22B
$6.40B
$6.26B
$6.17B
$6.30B
$6.53B
Cost of revenue
$2.90B
$2.69B
$2.52B
$2.29B
$2.38B
$2.12B
Gross profit
$3.31B
$3.71B
$3.75B
$3.88B
-
-
R&D
-
-
-
-
$443.00M
$210.00M
SG&A
OGN annual revenue (10-K history)
Organon & Co. reported annual revenue of $6.22B for fiscal year 2025. That is down 2.9% from $6.40B in fiscal 2024. Over the 7 fiscal years shown, annual revenue declined from $7.78B (FY 2019) to $6.22B. Figures come from the company's audited annual reports as filed with the SEC.
